IPO Insider

Highlighted IPO

On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.

J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.

Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.

Recently Priced IPOs

Date Company Ticker Shares IPO Price Current % Underwriters
10/12/2016 Azure Power Global AZRE 3.409 Mil $18.00 $15.93 -11.50% Barclays and Credit Suisse
10/11/2016 AzurRx BioPharma AZRX 960K $5.50 $5.03 -8.55% WallachBeth Capital, LLC and Network1 Financial Securities
10/6/2016 Coupa Software COUP 7.4 Mil $18.00 $27.00 50.00% Morgan Stanley, JPMorgan, Barclays, RBC Capital, JMP Securities, and Raymond James
10/19/2016 CRISPR Therapeutics CRSP 4 Mil $14.00 $14.70 5.00% Citigroup, Piper Jaffray, Barclays, Guggenheim Securities
10/7/2016 Camping World CWH 11.364 Mil $22.00 $22.64 2.91% Goldman, Sachs & Co. and J.P. Morgan
10/20/2016 Forterra FRTA 18.42 Mil $18.00 $16.87 -6.28% Goldman, Sachs & Co., Citigroup and Credit Suisse
10/20/2016 iRhythm Technologies IRTC 6.294 Mil $17.00 $26.26 54.47% J.P. Morgan and Morgan Stanley
10/7/2016 Everspin Technologies MRAM 5 Mil $8.00 $6.36 -20.50% Stifel and Needham & Company
10/6/2016 Obalon Therapeutics OBLN 5 Mil $15.00 $14.00 -6.67% UBS, Canaccord Genuity and Stifel
10/12/2016 Extraction Oil & Gas XOG 33.333 Mil $19.00 $21.97 15.63% Credit Suisse, Barclays, and Goldman Sachs

Upcoming IPOs

Date Company Ticker Shares Expected Price Underwriters
N/AloanDepot, Inc.LDI30 Mil$16-$18Morgan Stanley, Goldman Sachs, Wells Fargo, Barclays
N/Acongatec Holding AGCONG5.455 Mil$10-$12Stifel, Needham & Company
N/APLx Pharma Inc.PLXPN/AN/ARaymond James, Maxim Group, Janney Montgomery Scott
N/ATruck HeroTRUK11.111 Mil$17-$19J.P. Morgan, Baird, BofA Merrill Lynch
N/ATiGenix NVTIGN/AN/ACanaccord Genuity, Nomura Securities International, KBC Securities USA, Chardan Capital Markets
N/ABavarian Nordic A/SBAVNN/AN/ACowen and Company, Piper Jaffray, Nomura
N/AViamet Pharmaceuticals Corp.VMETN/AN/AMorgan Stanley, Goldman, Sachs & Co., Guggenheim Securities, Needham & Company
N/AMassRoots, Inc.MSRTN/AN/AChardan Capital Markets
N/AGemphire TherapeuticsGEMPN/AN/AJefferies and Cowen
N/AOrthoPediatrics Corp.KIDSN/AN/APiper Jaffray & Co., Stifel, Nicolaus & Company, William Blair & Company, BTIG

Upcoming IPO

Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.

The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.

Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.